Parkinson’s disease named as one of the consequences of COVID-19

COVID-19 can provoke or accelerate the development of a chronic brain disease, Parkinson’s disease.

Knowing the nature of Parkinson’s disease and the processes of formation of the corresponding protein structures that precede it, scientists assume that coronavirus infection can provoke them.

COVID-19 patients may suffer multifactorial damage to the central nervous system: the disease triggers many autoimmune processes in the body. We had assumed by the frequent symptoms of loss of smell that the coronavirus was affecting the central nervous system, but now we realize that it goes much further than that.

According to the latest WHO figures, there are more than 270 million infected people worldwide, of whom 5.3 million have not been rescued. The most difficult situation is in the United States, India, Brazil and the United Kingdom. Vaccination remains the most reliable method of protection. The proportion of those vaccinated among COVID-19 cases does not exceed four percent, severe cases are few, and the vast majority of patients in hospitals are unvaccinated. At the end of September, the WHO stated that mortality from SARS-CoV-2 is associated with the refusal of preventive immunization.